David Hansen, MD, MPH

A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Subtype-Selective JAK Inhibitors for Preservation of Pancreatic Beta Cell Function in Newly Diagnosed Type 1 Diabetes Mellitus
Read more

A Phase 3, Open-Label, Multicenter, Single-Arm Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Dulaglutide 3.0mg and 4.5mg in Pediatric Participants 10 to Less than 18 Years of Age with Type 2 Diabets Mellitus. (AWARDS-PEDS PLUS)
Read more

Efficacy and Safety of Tirzepatide Once Weekly versus Placebo for the Treatment of Obesity and Weight-Related Comorbidities in Adolescents: A Randomized, Double-Blind, Placebo-Controlled Trial.
Read more

TrialNet Natural History Study of the Development of Type 1 Diabetes (Pathway to Prevention)
Read more